Yoshinori Ikehata
Papers
17
Total Citations
84
H-Index
5
About
Yoshinori Ikehata is a leading urological surgeon and researcher whose work focuses on improving outcomes for prostate cancer patients undergoing robot-assisted radical prostatectomy (RARP). As a key member of the MSUG94 group, Dr. Ikehata has spearheaded landmark multicenter retrospective cohort studies across Japan that have reshaped clinical decision-making in robotic prostate surgery. His most impactful contributions include demonstrating that pelvic lymphadenectomy may not improve biochemical recurrence-free survival—a finding with significant implications for surgical practice—and developing a novel nomogram to predict lymph node involvement in the RARP era. Dr. Ikehata has also clarified the prognostic importance of lymphovascular invasion, positive surgical margin locations, and inflammation-related parameters such as the neutrophil-to-lymphocyte ratio. With over 70 citations across his top ten papers, his work has been instrumental in establishing evidence-based benchmarks for oncological and surgical outcomes in Japanese prostate cancer patients. His research continues to guide risk stratification and treatment personalization in robotic prostate surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10